Researchers identify genetic marker that could guide brain cancer treatment

University of Kentucky Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup